Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Preferred Dividend Payments (2024 - 2025)

Traws Pharma (TRAW) has disclosed Preferred Dividend Payments for 4 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • For Q4 2025, Preferred Dividend Payments rose 75.95% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached $3.1 million, up 102.67%, while the annual FY2025 figure was $2.3 million, 102.06% up from the prior year.
  • Preferred Dividend Payments hit -$2.0 million in Q4 2025 for Traws Pharma, down from -$927000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $6.4 million in Q1 2025 and bottomed at -$102.4 million in Q2 2024.